ESPE Abstracts (2015) 84 P-2-480

ESPE2015 Poster Category 2 Growth (38 abstracts)

In Vitro Functional Characterization Of IGFALS Gene Variants Found In ALS Deficient or Idiopathic Short Stature (ISS) Children

Lucia Martucci , Paula Scaglia , Liliana Karabatas , Rodolfo Rey , Horacio Domené , Sabina Domené & Héctor Jasper

Centro de Investigaciones Endocrinológicas “Dr. César Bergadá” (CEDIE) CONICET – FEI – División de Endocrinología, Hospital de Niños Ricardo Gutiérrez, Buenos Aires, Argentina

Background: ALS deficient (ALS-D) patients present severe IGFI and IGFBP3 deficiencies and variable degree of growth retardation. Heterozygous carriers for IGFALS variants, ALS-D relatives or a subset of ISS children, have levels of IGFI, IGFBP3 and ALS intermediate between ALS-D and wildtype (WT) subjects. This supports that IGFALS gene variants may affect ALS synthesis, secretion and/or function and could be responsible for the observed phenotype.

Objective and hypotheses: We aim to study the impact of ten IGFALS gene variants identified in ALS-D or ISS children (p.E35Kfs*87, p.E35Gfs*17, p.L213F, p.N276S, p.P287L, p.A330D, p.L409F, p.A475V, p.C540R, and p.R548W) on ALS protein synthesis and secretion and to characterize whether the secreted protein variants retain functional capacity for ternary complex formation in vitro (iv-TCF).

Method: IGFALS gene variants were introduced by site-directed mutagenesis into a commercial vector containing the entire human IGFALS cDNA. CHO cells were transiently transfected with WT-IGFALS or each of the ten variants. Both lysates and conditioned media (CM) were analyzed by WIB. Iv-TCF was performed for WT and mutant ALS variants by Superdex 200 exclusion column chromatography.

Results: WIB showed that WT-ALS was found mostly secreted into the CM at 24 hours. For variants p.E35Kfs*87, p.E35Gfs*17, p.N276S, p.L409F and p.C540R, we found absence of protein in both lysates and CM; for variant p.L213F, presence of protein in lysates but absence in CM; and for variants p.P287L, p.A330D, p.A457V, and p.R548W, presence of protein in lysates and CM. All the normally synthesized and secreted variants retained their ability for iv-TCF.

Conclusion: Six of the IGFALS gene variants analyzed impaired the biosynthesis, secretion and/or stability of the protein. All secreted variants retained the ability to form iv-TCF. It remains to be explored how these variants affect the IGF system in the context of a whole organism.

Funding information: This work was supported by grants from the Agencia Nacional de Promoción Científica y Tecnológica (PICT-2010 Nro.1916), and SANDOZ International GmbH, Business Unit Biopharmaceuticals.

Article tools

My recent searches

No recent searches.